Seizure frequency data were analyzed in patients who were randomized to and completed the @-week Maintenance Period of the phase III studies on perampanel @mg , and who received an actual ( last ) dose of @mg during ( @ ) the extension @-week blinded Conversion Period or ( @ ) weeks @-@ of the extension Maintenance Period .